| [1] Paneni F, Costantino S, Volpe M, et al. Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective. Atherosclerosis. 2013;230(2):191-197.[2] Ekmekci H,Ekmekci OB.The role of adiponectin in atherosclerosis and thrombosis. ClinApplThrombHemost. 2006; 12(2):163-168.[3] Suzuki M, Minami A, Nakanishi A, et al.Atherosclerosis and tumor suppressor molecules (review). Int J Mol Med. 2014 Oct;34(4):934-940.[4] Bao MH, Zhang YW, Zhou HH. Paeonol suppresses oxidized low-density lipoprotein induced endothelial cell apoptosis via activation of LOX-1/p38MAPK/NF-κB pathway. J Ethnopharmacol.2013;146(2):543-551. [5] Kim S, Kim CK, Lee KS, et al. Aqueous extract of unripe Rubuscoreanus fruit attenuates atherosclerosis by improving blood lipid profile and inhibiting NF-κB activation via phase II gene expression.J Ethnopharmacol. 2013;146(2):515-524.[6] Ku CS, Pham TX, Park Y, et al. Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes. BiochimBiophysActa.2013;1830(4):2981-2988. [7] Ozkanlar S, Akcay F. Antioxidant vitamins in atherosclerosis—animal experiments and clinical studies. AdvClinExp Med. 2011;10(2):591-608.[8] Bailey-Downs LC,Tucsek Z,Toth P,et al.Aging exacerbates obesity-inducedoxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A BiolSci Med Sci. 2013;68(7): 780-792. [9] Guo H, Chen Y, Liao L, et al. Resveratrol protects HUVECs from oxidized-LDL induced oxidative damage by autophagy upregulation via the AMPK/SIRT1 pathway.Cardiovasc Drugs Ther.2013;27(3):189-198.[10] Zhang HP, Zheng FL, Zhao JH, et al. Genistein inhibits ox-LDL-induced VCAM-1, ICAM-1 and MCP-1 expression of HUVECs through heme oxygenase-1. Arch Med Res. 2013; 44(1):13-20.[11] Qin B, Xiao B, Liang D, et al. MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis. BMB Rep. 2012; 45(8):464-469. [12] Zhang L, Zhou G, Song W, et al.Pterostilbene protects vascular endothelial cells against oxidized low-density lipoprotein-induced apoptosis in vitro and in vivo. Apoptosis. 2012;17(1):25-36.[13] 曹政,杨勇,华先平,等.脂联素对内皮祖细胞增殖和迁移能力的影响[J].中华老年心脑血管病杂志, 20l2,14(9):977-979.[14] 韩同英,马路一.肥胖大鼠血清脂联素水平与血管内皮NF-κB, VCAM-1,ICAM-1关系的研究[J].临床儿科杂志,2011, 29(7): 674-677.[15] Feng Y,Cai ZR,Tang Y,et al.TLR4/NF-κB signaling pathway-mediated andoxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions inhuman umbilical vein endothelial cells. Genet Mol Res.2014;13(1):680-695.[16] Mackesy DZ, Goalstone ML.Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells. J Inflamm (Lond) . 2011; 8:34.[17] Mitra S, Khaidakov M, Lu J, et al. Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation.Am J Physiol Heart Circ Physiol. 2011;301(2): H506-513. [18] Kuo MY, Ou HC, Lee WJ, et al.Ellagic acid inhibits oxidized low-density lipoprotein induced metalloproteinase (MMP) expression by modulatingthe protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signalingpathway in endothelial cells.J Agric Food Chem.2011; 59(9):5100-5108.[19] Melgarejo E, Medina MA, Sanchez-Jimenez F, et al.Monocyte chemoattractant protein-1: a key mediator in inflammatory processes.Int J Biochem Cell Biol. 2009; 41:998-1001.[20] Wang X,Pu H, Ma C,et al.Adiponectin abates atherosclerosis by reducing oxidative stress. Med SciMonit. 2014;20: 1792-1800.[21] Blum A. HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis. Biofactors. 2014; 40:295-302.[22] Lee S, Zhang H, Chen J, et al.Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice. Am J Physiol Heart Circ Physiol.2012; 303:H106-115.[23] Kempe S,Kestler H,Lasar A,et al.NF-kappa B controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Research.2005;33:5308-5319.[24] Heo KS, Cushman HJ, Akaike M, et al. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis. Circulation. 2014; 130:180-191.[25] Ishibashi S, Brown MS, Goldstein JL, et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest.1993; 92:883-893.[26] Khan R, Spagnoli V, Tardif JC, et al.Novel anti-inflammatory therapies for the treatment of atherosclerosis. Atherosclerosis. 2015; 240:497-509.[27] 张立功,王立俊,汪翼,等.OxLDL/LOX-1系统及NF-κB通路在糖尿病血管内皮功能障碍中的作用机制[J].中华内分泌代谢杂志, 2012, 28(7):589-592.[28] 刘婷,赵丽玲,廖二元,等.脂联素对主动脉平滑肌细胞体外钙化的影响[J].中国现代医学杂志,2010,20(9):2910-2913.[29] 王雪梅,蒲红伟,姜涛,等.脂联素通过减轻氧化应激治疗动脉粥样硬化的研究[J].生物医学工程研究, 2014,33(2):103-107.[30] Wang X, Chen Q, Pu H, et al. Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice. Lipids in Health and Disease. 2016; 15(1):33.[31] Pateras I, Giaginis C, Tsigris C, et al. NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links. Expert OpinTher Targets. 2014; 18(9): 1089-1101.[32] Shi J, Sun X, Lin Y, et al. Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-κB pathways. Biomaterials. 2014; 35(24): 6657-6666. [33] Sui Y, Park SH, Xu J, et al. IKKβ links vascular inflammation to obesity and atherosclerosis. J Exp Med. 2014; 211(5):869- 886.[34] Ren S, Fan X, Peng L, et al.Expression of NF-κB, CD68 and CD105 in carotid atherosclerotic plaque. J Thorac Dis. 2013; 5(6):771-776. |
.jpg)
.jpg)
.jpg)
.jpg)